Associated Papers
Loss-of-function Thr347Ala Variant in the G Protein Subunit-Α11 Causes Familial Hypocalciuric Hypercalcemia 2.
Boisen IM et al.
The Journal of Clinical Endocrinology and Metabolism, 2025
The Molecular Basis of Calcium and Phosphorus Inherited Metabolic Disorders.
Papadopoulou A et al.
Genes, 2021
[A series of clinical cases of familial hypocalciuric hypercalcemia syndrome].
Krupinova JA et al.
Problemy Endokrinologii, 2020
International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.
Leach K et al.
Pharmacological Reviews, 2020
The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases.
Hannan FM et al.
Nature Reviews. Endocrinology, 2018
Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway.
Hannan FM et al.
British Journal of Pharmacology, 2018
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
Howles SA et al.
Jci Insight, 2017
GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts.
Mayr B et al.
European Journal of Endocrinology, 2016
Select a paper to view details